Information Provided By:
Fly News Breaks for March 22, 2016
ACHC
Mar 22, 2016 | 07:49 EDT
Jefferies analyst Brian Tanquilut believes the recent pullback in shares of Acadia Healthcare has brought a "compelling" entry point into the name. Recent concerns about the potential British exit from the European Union and the progress of a Medicaid mental health bill in Congress are overblown, Tanquilut tells investors in a research note. Acadia's revenue can grow to $6B in 2020 given its continued government focus on mental health and aggressive M&A strategy, the analyst contends. He keeps a Buy rating on the shares with an $85 price target.